$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
美国辉瑞坦西莫司副作用有哪些
2025-10-19 11:44:20
Check Details
飞尼妥(依维莫司)副作用
2025-10-19 11:44:20
Check Details
坦罗莫司治疗肾癌的副作用是什么?需要注意什么?
2025-10-19 11:44:20
Check Details
英利达副作用处理方法
2025-10-19 11:44:20
Check Details
美国辉瑞axitinib的副作用大吗?
2025-10-19 11:44:20
Check Details
替沃扎尼的副作用有哪些,什么时候才能停药?
2025-10-19 11:44:20
Check Details
索拉非尼的副作用
2025-10-19 11:44:20
Check Details
替沃扎尼一年的费用是多少?
2025-10-19 11:44:20
Check Details
替沃扎尼治疗肾细胞癌:疗效优于索拉非尼!
2025-10-19 11:44:20
Check Details
替沃扎尼一个疗程是多久,一疗程多少钱?
2025-10-19 11:44:20
Check Details
替沃扎尼服用注意事项有哪些?
2025-10-19 11:44:20
Check Details
舒尼替尼2022价格,多少钱一盒?
2025-10-19 11:44:20
Check Details
1
2
...
2414
2415
2416
2417
2418
2419
2420
...
4156
4157
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Leflunomide and Ocular Adverse Effects: Risk Awareness and Clinical Guidance
2
Clinical Management of Acquired Resistance to Garsorasib (KRAS G12C Inhibitor)
3
Chemical Structure of Capivasertib: A Novel AKT Inhibitor
4
Capivasertib: An AKT Inhibitor for Breast and Prostate Cancer
5
Global Update 2026: Selumetinib (KOSELUGO) Expands Indication to Adult NF1-PN and Clinical Management Strategies
6
Lenvatinib Safety Guide: Baseline Assessment & Adverse Reaction Management
7
Inluriyo (Imlunestrant): Oral SERD for ER+/HER2- Breast Cancer with ESR1 Mutations
8
Idelalisib: Oral PI3Kδ Inhibitor for Relapsed/Refractory Hematologic Malignancies
9
Lorlatinib (Lorviqua): Oral Targeted Therapy for ALK-Positive Advanced Non-Small Cell Lung Cancer
10
FDA Approves Ibrance for New Maintenance Indication in HR+/HER2+ Breast Cancer
11
FDA Approves Trodelvy for Two First-Line Indications, Redefining Advanced Triple-Negative Breast Cancer Care
12
Cabozantinib: A Pan-Targeted TKI in Modern Oncology Practice